Tiềm năng ức chế sự lây truyền vi-rút SARS-CoV-2 qua đường miệng của keo ong
Từ khóa:
keo ong, SARS-CoV, COVID-19, ACE2, xoang miệngTóm tắt
Thế giới đang nỗ lực nghiên cứu và phát triển các biện pháp để đối phó với đại dịch toàn cầu nghiêm trọng COVID-19 do vi-rút Corona SARS-CoV-2 gây ra. Mặc dù phần lớn sự chú ý đang tập trung vào trục lây nhiễm mũi - phổi, SARS-CoV-2 cũng có thể lây truyền qua xoang miệng. Men chuyển angiotensin 2 (ACE2) hiện diện trong tế bào và mô miệng có thể là cửa ngõ xâm nhập của SARS-CoV-2. Keo ong (hỗn hợp nhựa tự nhiên do ong mật sản xuất) có thể ức chế sự liên kết giữa ACE2 với vi-rút. Keo ong còn cho thấy tác động có lợi ở bệnh nhân COVID-19. Do đó, sử dụng keo ong để phòng ngừa lây nhiễm qua xoang miệng có thể là một biện pháp bổ sung giúp ngăn chặn sự lây truyền SARS-CoV-2 và góp phần chống lại đại dịch COVID-19.
Tài liệu tham khảo
[1] N. Zhu, D. Zhang, W. Wang, ... and China Novel Coronavirus Investigating and Research Team, “A Novel Coronavirus from Patients with Pneumonia in China, 2019,” The New England Journal of Medicine, Vol. 382, No. 8, pp. 727-733, 2020. DOI:10.1056/NEJMoa2001017
[2] R. Zhang, Y. Li, A. L. Zhang, Y. Wang Y and M. J. Molina, “Identifying airborne transmission as the dominant route for the spread of COVID-19,” Proceedings of the National Academy of Sciences of the United States of America, Vol. 117, No. 26, pp. 14857-14863, 2020. DOI:10.1073/pnas.2009637117
[3] World Health Organization, “WHO Coronavirus (COVID-19) Dashboard”, 2021. Available: https://covid19.who.int/ [Accessed 09 03 2021].
[4] A. A. Berretta, M. A. D. Silveira, J. M. CóndorCapcha and D. De Jong, “Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease: Running title: Propolis against SARS-CoV-2 infection and COVID-19,” Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, Vol. 131, Article ID 110622, 2020. DOI:10.1016/j.biopha.2020.110622
[5] N. Huang, P. Pérez, T. Kato, … and K. M. Byrd, “SARS-CoV-2 infection of the oral cavity and saliva,” Nature Medicine, Vol. 27, No. 5, pp. 892-903, 2021. DOI:10.1038/s41591-021-01296-8
[6] W. G. Lima, J. C. M. Brito and W. S. da Cruz Nizer, “Bee products as a source of promising therapeutic and chemoprophylaxis strategies against COVID-19 (SARS-CoV-2),” Phytotherapy Research, Vol. 35, No. 2, pp. 743-750, 2021. DOI:10.1002/ptr.6872
[7] D. Bachevski, K. Damevska, V. Simeonovski and M. Dimova, “Back to the basics: Propolis and COVID-19,” Dermatologic Therapy, Vol. 33, No. 4, Article ID e13780, 2020. DOI:10.1111/dth.13780
[8] N. Ripari, A. A. Sartori, M. da Silva Honorio, … and J. M. Sforcin, “Propolis antiviral and immunomodulatory activity: a review and perspectives for COVID-19 treatment,” Journal of Pharmacy and Pharmacology, Vol. 73, No. 3, pp. 281-299, 2021. DOI:10.1093/jpp/rgaa067
[9] A. M. Ali and H. Kunugi, “Propolis, Bee Honey, and Their Components Protect against Coronavirus Disease 2019 (COVID-19): A Review of In Silico, In Vitro, and Clinical Studies,” Molecules, Vol. 26, No. 5, Article ID 1232, 2021. DOI:10.3390/molecules26051232
[10] V. D. Wagh, “Propolis: A wonder bees product and its pharmacological potentials,” Advances in Pharmacological Sciences, Vol. 2013, Article ID 308249, 2013. DOI:10.1155/2013/308249
[11] L. M. Santos, M. S. Fonseca, A. R. Sokolonski, ... and B. A. Machado, “Propolis: types, composition, biological activities, and veterinary product patent prospecting,” Journal of The Science of Food and Agriculture, Vol. 100, No. 4, pp. 1369-1382, 2020. doi:10.1002/jsfa.10024
[12] W. Sakaguchi, N. Kubota, T. Shimizu, ... and K. Tukinoki, “Existence of SARS-CoV-2 Entry Molecules in the Oral Cavity,” International Journal of Molecular Sciences, Vol. 21, No. 17, Article ID 6000, 2020. DOI:10.3390/ijms21176000
[13] S. Etemad-Moghadam and M. Alaeddini, “Is SARS-CoV-2 an Etiologic Agent or Predisposing Factor for Oral Lesions in COVID-19 Patients? A Concise Review of Reported Cases in the Literature,” International Journal of Dentistry, Vol. 2021, Article ID 6648082, 2021. DOI:10.1155/2021/6648082
[14] A. C. Khayrani, R. Irdiani, R. Aditama, ... and M. Sahlan, “Evaluating the potency of Sulawesi propolis compounds as ACE-2 inhibitors through molecular docking for COVID-19 drug discovery preliminary study,” Journal of King Saud University Science, Vol. 33, No. 2, Article ID 101297, 2021. DOI:10.1016/j.jksus.2020.101297
[15] H. I. Guler, G. Tatar, O. Yildiz, A. O. Belduz and S. Kolayli, “Investigation of potential inhibitor properties of ethanolic propolis extracts against ACE-II receptors for COVID-19 treatment by molecular docking study,” Archives of Microbiology, Vol. 20, No. 6, pp. 3557-3564, 2021. DOI:10.1007/s00203-021-02351-1
[16] F. Hussain, N. Jahan, K. U. Rahman, B. Sultana and S. Jamil, “Identification of Hypotensive Biofunctional Compounds of Coriandrum sativum and Evaluation of Their Angiotensin-Converting Enzyme (ACE) Inhibition Potential,” Oxidative Medicine and Cellular Longevity, Vol. 2018, Article ID 4643736, 2018. DOI:10.1155/2018/4643736
[17] Q. Wang, X. Sui, D. J. Sui and P. Yang, “Flavonoid Extract from Propolis Inhibits Cardiac Fibrosis Triggered by Myocardial Infarction through Upregulation of SIRT1,” Evidence-based Complement and Alternative Medicine, Vol. 2018, Article ID 4957573, 2018. DOI:10.1155/2018/4957573
[18] M. A. D. Silveira, D. De Jong, A. A. Berretta, ... and BeeCovid Team, “Efficacy of Brazilian green propolis (EPP-AF®) as an adjunct treatment for hospitalized COVID-19 patients: A randomized, controlled clinical trial,” Biomedicine & pharmacotherapy = Bio-medecine & pharmacotherapie, Vol. 138, Article ID 111526, 2021. DOI:10.1016/j.biopha.2021.111526
[19] M. F. Salas Orozco, N. Niño-Martínez, G. A. Martínez-Castañón, ... and M. A. Casillas Santana, “Presence of SARS-CoV-2 and Its Entry Factors in Oral Tissues and Cells: A Systematic Review,” Medicina (Kaunas), Vol. 57, No. 6, pp. 523, 2021. DOI:10.3390/medicina57060523
[20] M. Marshall, “COVID's toll on smell and taste: what scientists do and don't know,” Nature. Vol. 589, No. 7842, pp. 342-343, 2021. DOI:10.1038/d41586-021-00055-6.
[21] T. Koe, “New rules: South Korea expands propolis oral formats, removes upper limit for functional ingredients,” 2020. Available: https://www.nutraingredients-asia.com/Article/2020/03/09/ [Accessed 09 03 2021].
